Cite Filings / HRTX / 0001193125-26-196306
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
DEF 14A

Proxy Statement

HERON THERAPEUTICS, INC. /DE/ · Filed 2026-04-30 · Acc 0001193125-26-196306

Documents 1

  • DEF 14A Proxy Statement , hrtx-20260430.htm

Around this filing

  • 2026-05-04 4 EVP, Chief Development Officer acquired 23,464 shares (option exercise)
  • 2026-05-04 4 EVP, Chief Financial Officer acquired 25,229 shares (option exercise)
  • 2026-05-04 4 Chief Executive Officer acquired 84,810 shares (option exercise)
  • 2026-04-30 ARS Annual Report to Security Holders
  • 2026-04-30 DEFA14A Proxy Materials
  • 2026-04-30 DEF 14A Proxy Statement
  • 2025-09-19 DEF 14A Proxy Statement

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading hrtx-20260430.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…